Left ventricular ejection fraction < %
Subject must have a left ventricular ejection fraction of ? %;
Left ventricular ejection fraction greater than or equal to (>=)  percentage (%); >=% (cohort E only)
Left ventricular ejection fraction >= %
Left ventricular ejection fraction > %.
Left ventricular ejection fraction of < %
Left ventricular ejection fraction < %
Participant has left ventricular ejection fraction at rest ? %.
Subject has a documented left ventricular ejection fraction > %
Cardiac: left ventricular ejection fraction at rest must be ? %
Left ventricular ejection fraction > %
Left ventricular ejection fraction >= %.
Left ventricular ejection fraction of at least % by either echocardiography or radionucleotide angiography
Must have left ventricular ejection fraction > %
Left ventricular ejection fraction >= %.
Decreased cardiac function as evidenced by a left ventricular ejection fraction of < %
Cardiac: left ventricular ejection fraction < %
Left ventricular ejection fraction > %
Left ventricular ejection fraction > %
Left ventricular ejection fraction < %
Left ventricular ejection fraction of > %.
Left ventricular ejection fraction < %
Left ventricular ejection fraction >= %
Cardiac left ventricular ejection fraction >= % at rest
Left ventricular ejection fraction >= %
Must have left ventricular ejection fraction >= %
Must have left ventricular ejection fraction > %
Left ventricular ejection fraction >= %
Left ventricular ejection fraction < %
Left ventricular ejection fraction of at least % (nonmyeloablative regimen )
Absence of decompensated congestive heart failure, or uncontrolled arrhythmia and left ventricular ejection fraction >= %
Left ventricular ejection fraction >= %
Adequate cardiac function with a left ventricular ejection fraction >= %
Adequate cardiac function with left ventricular ejection fraction >= %
Systolic heart failure defined as left ventricular ejection fraction =< %
Adequate cardiac function with left ventricular ejection fraction >= %
The subject has a documented left ventricular ejection fraction > %
Left ventricular ejection fraction ? %
Left ventricular ejection fraction > %
PART : Left ventricular ejection fraction > % OR
Patients who have other medical conditions that would contraindicate treatment with aggressive chemotherapy (including active infection, uncontrolled hypertension, congestive heart failure, unstable angina pectoris, myocardial infarction within the past  months, or uncontrolled arrhythmia); if the patient's cardiac history is questionable, a measurement of left ventricular ejection fraction should be obtained within  days prior to registration; patients with left ventricular ejection fraction < % are not eligible
Left ventricular ejection fraction < %
Left ventricular ejection fraction at rest must be >= %
Left ventricular ejection fraction must be evaluated by nuclear medicine scan or echocardiography and measure >= %
Left ventricular ejection fraction >= %
Left ventricular ejection fraction equal or greater than %
Patients with symptomatic coronary artery disease, uncontrolled congestive heart failure; left ventricular ejection fraction is not required to be measured, however if it is measured, patient is excluded if ejection fraction is < %
Left ventricular ejection fraction greater than %
Left ventricular ejection fraction (EF) >= %
Left ventricular ejection fraction at rest must be >= %
Left ventricular ejection fraction > %
Left ventricular ejection fraction < %
Left ventricular ejection fraction >= %
Has Left Ventricular Ejection Fraction ? %
Left ventricular ejection fraction greater than %
Ventricular ejection fraction (VEF) =< % at baseline
Stable cardiac condition with a left ventricular ejection fraction of % or greater.
Left ventricular ejection fraction > %
Left ventricular ejection fraction less than %
Left ventricular ejection fraction at rest > % within  months of registration.
Left ventricular ejection fraction >= % OR
Absence of decompensated congestive heart failure, or uncontrolled arrhythmia and left ventricular ejection fraction ? %
Normal left ventricular ejection fraction, as defined by ejection fraction (EF) >= %
Left ventricular ejection fraction >= %
Left ventricular ejection fraction > % (within  days of treatment start)
Left ventricular ejection fraction at rest >= %
Patients with a left ventricular ejection fraction of < %
Patients with a left ventricular ejection fraction of < %
Severe cardiovascular disease (arrhythmias requiring chronic treatment, congestive heart failure or left ventricular ejection fraction < %)
Left ventricular ejection fraction > % estimated
Left ventricular function % or greater
All subjects must have left ventricular ejection fraction ?%.
Left ventricular ejection fraction < %
Left ventricular ejection fraction at rest > % within  months of registration
Participant's left ventricular ejection fraction is within normal institutional ranges
Left ventricular ejection fraction < %.
Left ventricular ejection fraction (LEF) >= %
Ventricular ejection fraction >= %
Left ventricular ejection fraction >= %
Left ventricular ejection fraction >= %
Left ventricular ejection fraction < % in patients with prior anthracycline use or otherwise at risk for left ventricular systolic dysfunction
Resting left ventricular ejection fraction <% at the time of screening
Reduced left ventricular ejection fraction (< %) or other evidence of cardiac dysfunction as determined by the investigator
Left ventricular ejection fraction (EF) >= %
Left ventricular ejection fraction > % OR
Cardiac disease with left ventricular ejection fraction of less than %
Left ventricular ejection fraction at least %
Left ventricular ejection fraction (EF) >= % with no uncontrolled arrythmias or symptomatic heart disease
Left ventricular ejection fraction of at least %
Patients with a ventricular ejection fraction (=< %), or respiratory compromise (FEV =< %)
Left ventricular ejection fraction < %
Left ventricular ejection function < %
Left ventricular ejection fraction < % by ECHO
Cardiac function - left ventricular ejection fraction >= %
Left ventricular ejection fraction < %
Patients who are receiving trastuzumab must have a left ventricular ejection fraction of >= %
Left ventricular ejection fraction < %
The patient has a left ventricular ejection fraction of < %
Left ventricular ejection fraction equal or greater than %
Patients must have left-ventricular ejection fraction > % at baseline
Left ventricular ejection fraction (EF) < %
No symptoms of uncontrolled cardiac disease, left ventricular ejection fraction >= %
Suboptimal cardiac function as defined by decreased left ventricular ejection fraction < % for cohort , and < % for cohort 
Left ventricular EF > %.
Left ventricular ejection fraction of at least -%
Left ventricular ejection fraction (EF) < % at baseline
Normal estimated left ventricular ejection fraction and no history of ischemic heart disease requiring revascularization, unless cleared by a cardiologist
Left ventricular ejection fraction >= %
Left ventricular ejection fraction < %
Left ventricular ejection fraction
Left ventricular ejection fraction <  %.
Baseline left ventricular ejection fraction > or = %
Left ventricular ejection fraction
Ventricular ejection fraction (VEF) =<  % at baseline
Recipient must have adequate cardiac function with a left ventricular ejection fraction > %.
Left ventricular ejection fraction > % or the institutional LLN within  days prior to the first dose of study treatment.
Left ventricular ejection fraction <% or symptomatic cardiac disease, or myocardial infarction within the past  months
Left ventricular ejection fraction >= %
Left ventricular ejection fraction of > %
Has a pre-treatment transthoracic echocardiography (TTE) showing a calculated left ventricular ejection fraction of less than %
Subject has a left ventricular ejection fraction ?%.
Normal cardiac function (left ventricular ejection fraction >= %)
Normal cardiac function (left ventricular ejection fraction >= %)
Left ventricular ejection fraction > %
Left ventricular ejection fraction > %
Absence of decompensated congestive heart failure, or uncontrolled arrhythmia and left ventricular ejection fraction >= %